ArticleFrontiers in pharmacology2020

Preparation of a Growth Hormone Receptor/Prolactin Receptor Bispecific Antibody Antagonist Which Exhibited Anti-Cancer Activity.

Xin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.